See also this year's filing and all EDGAR filings for this company.
PDF Report 0001618561_2015_Nexvet_Biopharma_plc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001618561, Nexvet Biopharma plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 33,088,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,000 |
| 2 | PropertyPlantAndEquipmentNet | 514,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 3,197,000 |
| 5 | LiabilitiesNoncurrent | 5,538,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,426,000 |
| 9 | ResearchAndDevelopmentExpense | 5,617,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 3,667,000 |
| 12 | remainder_NetIncome | -334,000 |
| 13 | remainder_ComprehensiveNetIncome | 302,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 33,604,000 |
| 1 | Liabilities | 8,735,000 |
| 2 | Expenses | 10,043,000 |
| 3 | Revenues | 3,667,000 |
| 4 | StockholdersEquity | 24,869,000 |
| 5 | NetIncome | -6,710,000 |
| 6 | ComprehensiveNetIncome | -6,559,000 |
| 7 | BaseVar | 28,342,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.25 |
| 9 | EconomicCapitalRatio | 3.19 |
Edgar->Model Mapping
Feature Distribution
